Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ezra M. Friedberg currently holds 81,883 shares of Chromocell Therapeutics Corp (CHRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ezra M. Friedberg has been a net seller of CHRO stock. They have purchased $100.0K and sold $280.3K worth of shares.
Ezra M. Friedberg's most recent insider trade was on May 14, 2026, when they sold 144 shares at $27.01 per share.
Ezra M. Friedberg serves as Executive at Chromocell Therapeutics Corp (CHRO). They have executed 14 insider transactions totaling $380.3K over their tenure at the company.
Ezra M. Friedberg holds the position of Executive at Chromocell Therapeutics Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Ezra M. Friedberg has shown a selling trading pattern, with $100.0K in total purchases and $280.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Ezra M. Friedberg was on Jul 1, 2025, when they sold $400.0K worth of PTHS shares. This transaction involved 40,000 shares at $10.00 per share.
Ezra M. Friedberg currently owns 81,883 shares of Chromocell Therapeutics Corp (CHRO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ezra M. Friedberg's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ezra M. Friedberg has 14 Form 4 filings on record as an insider at Chromocell Therapeutics Corp.
Set alerts for Ezra M. Friedberg and 40,000+ other insiders.